SHANGHAI HAOYUAN CHEMEXPRESS CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 32.05 CNY | -2.88% |
|
-8.30% | -38.44% |
| 29/04 | Shanghai Haoyuan Chemexpress Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 25/03 | Haoyuan Chemexpress to Issue 822 Million Yuan Worth of Convertible Bonds | MT |
ETFs positioned on Shanghai Haoyuan Chemexpress Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +4.18% | - |
Shanghai Haoyuan Chemexpress Co Ltd is a China-based company mainly engaged in the research and development, production and sales of small molecule drugs. The Company's main products include molecular building blocks and tool compounds. The Company's products also include active pharmaceutical ingredients (APIs) and intermediates. The Company also provides related services such as contract research organization (CRO) service. The Company's molecular building blocks and tool compounds are applied in all stages of the drug discovery process. The Company distributes its products in domestic market and to overseas markets.
Sector
Pharmaceuticals
Calendar
22/08/2024
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
32.05
Average target price
-
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -38.44% | 686M | |
| -1.26% | 89.46B | |
| +2.76% | 40.74B | |
| -9.08% | 33.03B | |
| +55.32% | 24.68B | |
| -16.74% | 15.12B | |
| -8.98% | 12.81B | |
| -12.11% | 11.79B | |
| -43.61% | 11.64B | |
| +7.79% | 8.9B |
- Stock Market
- Equities
- 688131 Stock
- Funds and ETFs Shanghai Haoyuan Chemexpress Co., Ltd.
